|
|
Board at Anteo Diagnostics
| |
James Henderson,
Chairman and Non-Executive DirectorJames is the Managing Director of Transocean Group Pty Ltd. having many years experience in advising emerging companies. His core expertise is in corporate strategy and structure, capital raising and commercial negotiations. He advises companies across a number of industry sectors and has proven ability to assist companies execute their business plans. James has 15 years experience in equity capital markets and related areas. Currently, he is Chairman and/or Director of 4 listed companies.
|
| |
 |
Richard Martin
Non-Executive DirectorMr Richard Martin is a Director of the venture capital group First Cape Management. Mr Martin began his career working as a Chartered Accountant in public practice and has been a partner in the accounting firm of Trood Pratt & Co. His work has included complex business structuring and financing, the public listing of companies, the management of foreign currency portfolios, and the negotiation and implementation on the purchase and sale of small & large enterprises.
|
| |
| |
Ms Lara Iacusso
Non-Executive DirectorLara is a Director of Transocean Group Pty. Ltd. and a chartered accountant with over 20 years experience in providing investment banking and corporate finance services to emerging companies, including the medical products and diagnostics sector. She specialises in providing advice relating to corporate transactions and strategies including overall project management, valuation, due diligence and other transaction support, corporate advice assocaited with transactions, stock exchange listings, capital raisings and commercial negotiations.
Prior to joining Transocean Lara was a Corporate Finance partner with Deloitte in Australia. |
| |
| |
Robert Gilmour
Non-Executive DirectorWith degrees in Biochemistry and Medicine from the University of Otago, New Zealand, Robert has held academic teaching positions at Monash University, Melbourne, and Stanford University, Palo Alto, and pursued orthopaedic training in Melbourne Australia. Robert is a founder of Bodyworks Healthcare in New Zealand and Bodyworks Inc in California. He is a director and significant shareholder in Omni Life Science Inc, a US orthopaedic implant maker, as well as being the NZ based Managing Director of San Diego based VC firm Finistere Partners which is focused on device and diagnostic assets. Robert is the founding director and a significant shareholder in a NZ based diagnostic investment company known as NZDX. Robert is a senior advisor to the Foundation for Research Science and Technology in New Zealand and has an extensive network in California, particularly in the diagnostic market segment.
|
| |
|